Estimating the value of generic entry and intellectual property litigation in the pharmaceutical market
| Autor: | Koki Arai, Yuji Akematsu |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Finance
Economics and Econometrics 050208 finance Market competition Brand names business.industry media_common.quotation_subject 05 social sciences Pharmaceutical market Intellectual property 0502 economics and business Political Science and International Relations Value (economics) Economics 050207 economics business Industrial organization Reputation media_common |
| Zdroj: | Japan and the World Economy. 40:16-20 |
| ISSN: | 0922-1425 |
| DOI: | 10.1016/j.japwor.2016.10.001 |
| Popis: | In this study, we examine the relationship between, and implications of, the market entry and intellectual property litigation of brand name and generic pharmaceuticals from 2003 to 2012 in Japan. We focus on the effects of a firm’s litigation behavior on market competition, including not only anticipated damage and injunction costs but also reputation and reliability costs. The results show that market entry of generic pharmaceuticals decreases market sales of brand name pharmaceuticals by 45%. However, in the case of intellectual property rights, litigation increases market sales of branded pharmaceuticals by 120%. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect